NCS Multistage Holdings Inc (NCSM) Given Consensus Rating of “Buy” by Brokerages
Shares of NCS Multistage Holdings Inc (NASDAQ:NCSM) have received an average rating of “Buy” from the ten analysts that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, six have issued a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $27.60.
Several analysts have recently commented on NCSM shares. Royal Bank of Canada lowered their target price on shares of NCS Multistage from $30.00 to $25.00 and set an “outperform” rating for the company in a report on Wednesday, November 15th. UBS upgraded shares of NCS Multistage from an “outperform” rating to a “strong-buy” rating in a report on Wednesday, November 15th. Citigroup set a $32.00 target price on shares of NCS Multistage and gave the company a “buy” rating in a report on Thursday, October 5th. Zacks Investment Research downgraded shares of NCS Multistage from a “buy” rating to a “sell” rating in a report on Saturday, November 18th. Finally, Raymond James Financial upgraded shares of NCS Multistage from an “outperform” rating to a “strong-buy” rating in a report on Wednesday, November 15th.
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. FMR LLC purchased a new stake in NCS Multistage during the second quarter worth about $55,521,000. Lazard Asset Management LLC purchased a new stake in NCS Multistage during the second quarter worth about $38,015,000. Boston Partners purchased a new stake in NCS Multistage during the third quarter worth about $22,021,000. Goldman Sachs Group Inc. purchased a new stake in NCS Multistage during the second quarter worth about $21,959,000. Finally, Vanguard Group Inc. purchased a new stake in NCS Multistage during the second quarter worth about $13,697,000. Institutional investors and hedge funds own 93.02% of the company’s stock.
Shares of NCS Multistage (NASDAQ NCSM) traded up $0.23 during mid-day trading on Monday, hitting $14.51. 277,919 shares of the stock traded hands, compared to its average volume of 184,228. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.31 and a quick ratio of 2.29. NCS Multistage has a 52 week low of $13.85 and a 52 week high of $29.07.
NCS Multistage (NASDAQ:NCSM) last announced its earnings results on Monday, November 13th. The company reported $0.09 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.12 by ($0.03). The firm had revenue of $55.96 million during the quarter, compared to analysts’ expectations of $58.92 million. NCS Multistage had a net margin of 2.42% and a return on equity of 2.22%. equities research analysts anticipate that NCS Multistage will post 0.2 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: “NCS Multistage Holdings Inc (NCSM) Given Consensus Rating of “Buy” by Brokerages” was first published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of international trademark and copyright legislation. The original version of this news story can be read at https://theolympiareport.com/2017/12/16/ncs-multistage-holdings-inc-ncsm-given-consensus-rating-of-buy-by-brokerages.html.
About NCS Multistage
NCS Multistage Holdings, Inc is a provider of engineered products and support services for oil and natural gas well completions and field development strategies. The Company’s products and services include Multistage Unlimited, casing-installed sliding sleeves, downhole frac isolation assembly, AirLock casing buoyancy system and liner hanger systems.
Receive News & Ratings for NCS Multistage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCS Multistage and related companies with Analyst Ratings Network's FREE daily email newsletter.